Home Tags Neurodegenerative Diseases

Neurodegenerative Diseases Related Content

challenge of dementia

A balanced approach to the global challenge of dementia

Dr Yves Joanette, Scientific Director at the CIHR Institute of Aging argues for a balanced approach when it comes to their collaboration-based approach to face the challenge of dementia
Rett syndrome

Rett syndrome: Research on severe neurodevelopmental disorders

Jennifer J. McComas from the University of Minnesota discusses the current evidence for communication intervention for individuals with Rett syndrome
Neurodegenerative disorders

Neurodegenerative disorders in the U.S.

The vital work of the National Institute on Deafness and Other Communication Disorders (NIDCD) and The National Institute of Neurological Disorders and Stroke (NINDS) are explored here by Open Access Government, with a special focus on neurodegenerative disorders.
Alzheimer’s disease

Infections may be the new paradigm explaining the pathogenesis of Alzheimer’s disease

Tamas Fulop from Université de Sherbrooke’s Research Center on Aging, explains precisely why infections may be the new paradigm explaining the pathogenesis of Alzheimer’s disease (AD)
spinal cords

ALS researchers begin recreating human spinal cords on a chip

NIH-funded study closes in on personalised drug testing for neurological disorders
ageing process

Research suggests neurodegenerative disorders may speed up ageing process

Scientists from the National Institutes of Health (NIH) compared the genetic clocks of normal and mutant flies to understand the link between neurodegenerative disorders such as Alzheimer’s disease and the ageing process
Huntington’s disease (HD)

Ground-breaking results for Huntington’s Disease (HD) research

Svein Olaf Olsen and Maiken Arnesen from the European Huntington Association reveal their thoughts on a recent and significant breakthrough concerning Huntington’s Disease (HD) research The 11th December 2017 will probably go into history along with the discovery of the Huntington gene in 1993. On this date, IONIS Pharmaceuticals announced...
drug development for neurodegenerative diseases concept

Time for a change of tack on drug development for neurodegenerative diseases?

UCB's Duncan McHale outlines why reclassification might be a good idea to boost drug development for neurodegenerative diseases like Alzheimer's and Parkinson's Neurodegenerative diseases are a growing global challenge, as medical advances ensure more individuals live longer. By 2020 there will be more than 40 million people in the world...
composite scale

Positive progress for people with Parkinson’s

The European Parkinson’s Disease Association (EPDA) provide an update about the positive progress being made for people with Parkinson’s My PD Journey is a multi-stakeholder European coalition led by the European Parkinson’s Disease Association (EPDA) and it is a positive development in terms of the positive progress being made for...
precision medicine

Alzheimer’s as a spectrum disorder: The promise of precision medicine

Emory University’s Stuart Zola considers the case for classifying Alzheimer’s disease as a spectrum disorder and the promise of precision medicine as an intervention.
huntington's

New drug discovery may stop Huntington’s disease

The defect that causes Huntington's disease has been corrected in patients for the first time with an experimental drug Experts believe that the new experimental drug, which is injected into spinal fluid, could be the biggest breakthrough in neurodegenerative diseases for 50 years. The unstoppable death of brain cells in Huntington's gradually causes...

PET imaging of neurodegenerative diseases

Prof. Dr Axel Rominger from the Ludwig-Maximilian-University of Munich on how neurodegenerative diseases can be studied through PET imaging
Alzheimer's disease

Alzheimer’s disease: Treatment failures and future directions

A paradigm shift is needed if researchers are to find a successful for treatment for Alzheimer’s disease, argues Ai-Ling Lin of the Lin Brain Lab.
symptoms of Parkinson's

Treatments and symptoms of Parkinson’s

Prof. David Dexter, deputy director of research at Parkinson’s UK shares his thoughts on the symptoms of Parkinson’s and the chances of finding a cure
progressive condition

Dementia as a progressive condition

The Alzheimer's Society in the UK provides a fascinating glimpse into the most dementia as a progressive condition and its common forms
HTT in gene expression

New functions of HTT in gene expression

Naoko Tanese from New York University explores how monitoring gene expression can be used to treat neurodegenerative diseases such as Huntington's
nerve stimulator

Man in vegetative state regains some consciousness through nerve stimulator therapy

A man in a vegetative state in France has regained a degree of consciousness after experimental therapy of placing a nerve stimulator on his chest After being in a vegetative state for 15 years, the unnamed 35-year-old patient responded to nerve stimulator therapy and within a month was able to...

Tackling cognitive decline in Alzheimer’s disease

Ai-Ling Lin PhD, of The Lin Brain Lab talks about the reversal of cognitive decline in Alzheimer’s disease with comprehensive and personalised nutrition Alzheimer’s disease (AD) represents the most common cause of dementia, accounting for 60% to 80% of all dementia cases. There are currently only a few interventions that...
public health

Recognising dementia as a public health priority

The World Health Organization, says recognising dementia as a public health priority is key to addressing the condition globally

The role of physiotherapy for Parkinson’s

Writing on behalf of the Chartered Society of Physiotherapy, Dr. Bhanu Ramaswamy highlights how physiotherapy can help manage the symptoms of Parkinson’s

Follow Open Access Government